# Parabilis Medicines

**Canonical:** https://apis.io/providers/parabilis-medicines/  
**Website:** https://parabilismed.com  
**APIs profiled:** 0

Parabilis Medicines (formerly FogPharma) is a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, developing a new class of ultra-tunable alpha-helical peptide therapeutics called Helicons to reach intracellular protein targets long considered undruggable. Its AI- and physics-based discovery platform underpins a pipeline led by zolucatetide, a candidate targeting the beta-catenin / TCF interaction in the Wnt signaling pathway across multiple cancers. Backed by more than $500M from leading life sciences investors and public since its June 2026 IPO (Nasdaq: PBLS), the company was surfaced as a portfolio company of General Catalyst and GV. It publishes a public marketing and investor web presence and a science/data tech blog, but exposes no public developer API surface.

## Kin Score — 9.5 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 9.5).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 2.4 |
| Commercial Clarity | 21.1 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 17.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Parabilis Medicines Domain Security** — TLSv1.3 · DNSSEC · DMARC

## Tags

Company, Biotechnology, Pharmaceuticals, Oncology, Drug Discovery, Peptide Therapeutics, Life Sciences

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/parabilis-medicines/). Scores are computed from the provider's own public artifacts under a published rubric.